Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Close this folder11. Organizational and legal issues
View the document11.1 Introduction
View the document11.2 Why does a drug bulletin need a structure?
Open this folder and view contents11.3 Different kind of structures
View the document11.4 How to deal with legal action
Close this folder11.5 Copyright
View the document11.5.1 Limits to copyright
View the document11.5.2 How is copyright created?
View the document11.5.3 How to use copyrighted material
View the document11.5.4 Fair use and quotes
View the document11.6 Further reading
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

11.5.1 Limits to copyright

Copyright law also limits the granting of copyright protection for social policy reasons, such as the need to have access to certain knowledge and news about events in the world. For example, the news of the day published, broadcast or publicly communicated is not protected. Other unauthorised use of copyright material is generally accepted under the notion of ‘fair use’ (see below).

Copyright rules are fairly similar worldwide because of international treaties. The most important treaty is the Berne Convention, which was signed by 100 member countries. In general, copyright protection lasts for at least the author’s lifetime plus 50 years.

For drug bulletins copyright is important because it provides a way to protect their work against unauthorised reproduction by others. For example, a bulletin can prevent drug companies from photocopying or reprinting their articles for promotional use. Drug bulletins also need to be aware of the copyright of others.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017